Haratala Bhasma

Names and identification

Language	Name
English	Haratala Bhasma

Key Phytochemical Constituents

• Arsenic trisulfide (As2S3) as primary constituent
• Arsenic in sulfide-bound form (reduced bioavailability)
• Calcium arsenate traces
• Sulfur compounds
• Organic residues from herbal processing

How does it work?

• Anti-leukemic potential: Shodhana may enhance synergistic effect of Haratala in cellular apoptosis for leukemia treatment, analogous to arsenic trioxide (approved drug) mechanism
• Kaphahara (Kapha-reducing) action through stimulation of respiratory secretion clearance and bronchodilation, used traditionally for Shwasa (asthma) and Kasa (cough)
• Kushthahara (skin disease management) through antimicrobial and keratolytic effects on skin lesions, traditionally used for chronic dermatological conditions
• Jvaraghna (antipyretic) action through modulation of inflammatory pathways involved in fever generation

Which traditional uses are supported by research?

• Skin diseases (Kushtha): Traditional use partially supported by arsenic’s known keratolytic properties, though modern safer alternatives exist
• Asthma/respiratory disorders (Shwasa/Kasa): Some mechanistic support from bronchodilatory and mucolytic effects, but arsenic toxicity makes this indication unjustifiable
• Leukemia treatment: PARADOXICALLY VALIDATED - Arsenic trioxide is FDA-approved for acute promyelocytic leukemia. Haratala’s apoptotic mechanism aligns with this approved indication.

What do recent clinical trials show?

3 further claims previously listed here could not be traced to a published paper and have been removed. An absence here means we could not identify the source, not that no work exists.

Recent safety updates

• ARSENIC IS A GROUP 1 CARCINOGEN: IARC classifies arsenic and arsenic compounds as definite human carcinogens. Long-term exposure causes multiple cancers (lung, skin, bladder, liver).
• INSOLUBLE FORM REDUCES ACUTE TOXICITY: Properly prepared Haratala Bhasma contains arsenic in insoluble sulfide form, which may reduce acute oral toxicity compared to soluble arsenite/arsenate
• BLOOD ARSENIC INCREASES: Even with purified preparation, blood arsenic levels increase significantly during use (confirmed in human volunteer study), indicating systemic absorption occurs
• PREPARATION-CRITICAL: Without proper Shodhana and Marana, Haratala causes burning sensation, tremors, blood vitiation, skin disease, and potentially death. ONLY classically prepared products should be considered.
• NO LONG-TERM SAFETY DATA: Short-term studies show apparent safety, but chronic arsenic exposure effects (cancer, neuropathy, cardiovascular disease) may take years to manifest
• FDA/WHO POSITION: Arsenic in medicines not endorsed. WHO limit for arsenic in herbal medicines is 10 mcg/g. Most Haratala preparations far exceed this.

What is it made of?

Mineral/Elemental Profile

• Arsenic trisulfide (As2S3): Major component (orpiment)
• Note: Highly toxic — restricted use; Shodhana mandatory; modern practice largely discontinued

Analytical Methods: AAS (arsenic quantification), ICP-MS, XRD

Dosage forms and preparation

Dosage Forms: Bhasma (only after rigorous Shodhana)

Standard Dosage: 30–60 mg (strict dosing)

Bioavailability: Converted to non-toxic arsenic compound through proper Shodhana and Marana

Optimal Timing: As directed by experienced physician only

Standardized Extract: Purified and calcined orpiment (arsenic trisulfide) bhasma

Shelf Life: Indefinite

Storage: Airtight, labeled container; Schedule E1 drug

Marker Compounds: Arsenic sulfide (raw), Arsenic oxide (post-calcination), Sulfur compounds

Quality Parameters: Free arsenic <3 ppm (critical safety parameter), standard bhasma tests, particle size <100 nm

Vehicle (Anupana): Honey or ghee; only as part of specific formulations